completely wide open. They can start selling the technology to hospitals everywhere.
The company’s website states they use “affordable technology” to lower the cost of cancer screenings. According to them, this reduces the liability insurance premium for physicians and care providers.
Lower insurance premiums mean less money is required to get a screening, making it more affordable for those who come from low-income backgrounds.
RELATED: Can This Drug Reduce Hair Loss AND Prevent Cancer?
What Does This Mean For Prostate Cancer Patients?
Prostate cancer treatment’s future is bright as this new AI receives FDA approval. Now the small Nebraskan company can spread its technology to each corner of the US and slowly phase out painful biopsies and invasive prostate tests.
That is a relief because biopsies are not only painful but also very costly. Some of the more expensive ones can get upwards of $1,000. Most people who don’t have the best insurance may have to pay that out of pocket.
However, there are still drawbacks to MRI screenings that this new technology may have addressed. In recent years, a patient could see a bill for $500 if they need an MRI for prostate cancer.
Additionally, several community hospitals do not even offer MRI screenings, and if they do, the accuracy is highly questionable. That means you may not be able to get an MRI unless you live in a big city with a major health center.
Undoubtedly, this new FDA approval has quickened the pace of the steady progress towards better health for prostate cancer patients. If everything goes well, MRIs could become a cheaper, more efficient way to fight against the disease.